H.R. 8005
Stop Pills That Kill Act
Sponsor: Gabe Evans · 0 cosponsors
Official summary
Written by the Congressional Research Service.
Stop Pills That Kill Act
This bill increases criminal penalties for offenses relating to the manufacture of fentanyl or counterfeit substances. It also establishes requirements for federal agencies to address the use of counterfeit substances.
Specifically, the bill applies an increased criminal penalty for possessing, manufacturing, or distributing certain equipment or materials that are used to illegally manufacture fentanyl, an analogue of fentanyl, or a counterfeit substance (the increased penalty is currently limited to offenses involving methamphetamine).
The Drug Enforcement Administration must establish and implement a plan to address counterfeit fentanyl or methamphetamine substances through law enforcement action and education and prevention efforts. In addition, the Department of Justice must annually report on the collection of counterfeit fentanyl or methamphetamine substances by law enforcement and on related prosecutions.
Text of the bill
Where this section came from
Not in the first version (Introduced in House, Mar 19).
-
Sep 15, 2026 · Engrossed in House Marked up by House Committee on Energy and Commerce, Jul 20 Marked up by House Committee on Energy and Commerce, Jul 21 Committee members' individual votes aren't in our records.
What is a markup?
A markup is a committee meeting where members go through a bill and vote on changes before sending it to the full chamber.
(a) Definitions. Section 102 of the Controlled Substances Act (21 U.S.C. 802) is amended—
(1) by striking paragraph (38) and inserting the following:
(38) The term regulated person means a person who—
(A) manufactures, distributes, imports, or exports a listed chemical;
(B) manufactures, distributes, delivers, sells, imports, or exports a tableting machine, encapsulating machine, or critical part of a tableting or encapsulating machine; or
(C) acts as a broker or trader for a regulated transaction involving a listed chemical, tableting machine, encapsulating machine, or critical part of a tableting or encapsulating machine.
(2) by striking paragraph (39)(B) and inserting the following:
(B) a distribution, delivery, sale, importation, exportation, or international transaction of a tableting machine, encapsulating machine, or critical part of a tableting or encapsulating machine.
(3) in paragraph (42), by inserting , tableting machine, encapsulating machine, or critical part of a tableting or encapsulating machine after listed chemical;
(4) in paragraph (43), in the matter preceding subparagraph (A)—
(A) by striking an international and inserting a regulated; and
(B) by inserting , tableting machine, encapsulating machine, or critical part of a tableting or encapsulating machine after listed chemical; and
(5) by adding at the end the following:
(61) The term critical part, when used in reference to a tableting or encapsulating machine, means any of the following integral parts of a tableting or encapsulating machine:
(A) An upper punch.
(B) A lower punch.
(C) A die.
(D) Any additional parts that the Attorney General has determined to be integral to the operation of a tableting or encapsulating machine, provided that such determination—
(i) is made through rulemaking; and
(ii) does not go into effect until the rulemaking process has been completed.
(62) The term die means a tool that serves as the mold in which a product is compressed to form the desired size and shape of a tablet or capsule.
(63) The term lower punch means the punch inserted into the turret below the die.
(64) The term punch means a rod-shaped tool used in producing tablets and other products.
(65) The term upper punch means the punch inserted into the turret above the die.
(b) Regulation
(1) Records of regulated transactions. Section 310(a) of the Controlled Substances Act (21 U.S.C. 830(a)) is amended—
(A) in paragraph (1), by striking or an encapsulating machine and inserting , encapsulating machine, or critical part of a tableting or encapsulating machine; and
(B) in paragraph (2)—
(i) by striking or encapsulating machine and inserting , encapsulating machine, or critical part of a tableting or encapsulating machine; and
(ii) by inserting before the period at the end the following: and shall identify the tableting machine, encapsulating machine, or critical part of a tableting or encapsulating machine by means of a serial number that is engraved, cast, or otherwise permanently affixed to a nonremovable part of the tableting machine, encapsulating machine, or critical part of a tableting or encapsulating machine.
(2) Reports to attorney general. Section 310(b)(1) of the Controlled Substances Act (21 U.S.C. 830(b)(1)) is amended by striking subparagraph (D) and inserting the following:
(D) any regulated transaction in a tableting machine, encapsulating machine, or critical part of a tableting or encapsulating machine, including the serial number affixed to the tableting machine, encapsulating machine, or critical part of a tableting or encapsulating machine.
(3) Regulations
(A) In general. Not later than 180 days after the date of enactment of this Act, the Attorney General shall promulgate regulations carrying out the amendments made by paragraphs (1) and (2).
(B) Inclusion. The regulations required under subparagraph (A) shall include requirements regarding serial numbers affixed to tableting machines, encapsulating machines, or critical parts of tableting or encapsulating machines manufactured on or before the date of enactment of this Act.
(4) Applicability
(A) In general. Except as specified in subparagraph (B), the amendments made by paragraphs (1) and (2) shall apply only to any tableting machine, encapsulating machine, or critical part of a tableting or encapsulating machine manufactured, distributed, delivered, sold, imported, exported, or included in an international transaction after the effective date of the regulations promulgated under paragraph (3).
(B) Exception. Beginning on the date that is 180 days after the date of the enactment of this Act, the amendments made by paragraph (1) of this subsection to paragraphs (1) and (2) of section 310(a) of the Controlled Substances Act (21 U.S.C. 830(a)) shall apply with respect to a tableting machine, encapsulating machine, or critical part of a tableting or encapsulating machine manufactured on or before the date of enactment of this Act.
(c) Prohibited acts. Section 403(a) of the Controlled Substances Act (21 U.S.C. 843(a)) is amended—
(1) in paragraph (8), by striking or at the end;
(2) in paragraph (9), by striking the period at the end and inserting a semicolon; and
(3) by adding at the end the following:
(10) to remove, alter, or obliterate any serial number affixed to a tableting machine, encapsulating machine, or critical part of a tableting or encapsulating machine, that is required to have a serial number and with reasonable cause to believe the serial number is so required; or
(11) to transport, ship, receive, possess, distribute, deliver, sell, import, or export a tableting machine, encapsulating machine, or critical part of a tableting or encapsulating machine that is required to have a serial number, knowing that the serial number has been removed, altered, or obliterated, and with reasonable cause to believe the serial number is so required.